Article
Update in genetic susceptibility in melanoma.
1 Sept 2015
Abstract excerpt
Melanoma is the most deadly of the common skin cancers and its incidence is rapidly increasing. Approximately 10% of cases occur in a familial context. To date, cyclin-dependent kinase inhibitor 2A (CDKN2A), which was identified as the first melanoma susceptibility gene more than 20 years ago, is the main high-risk gene for melanoma. A few years later cyclin-dependent kinase 4 (CDK4) was also identified as a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
